Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Arotech Corporation (NASDAQ: ARTX) on Behalf of Arotech Shareholders and Encourages Arotech Investors to Contact the Firm

Stock Information for Fibrocell Science Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Fibrocell Science Inc.

Greenbriar Equity Group Completes Acquisition of Arotech Corporation
Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corporation (ARTX) to Contact Firm
Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders - FCSC, PRTO, ARTX, ROAN
Arotech to Release Third Quarter 2019 Results on Wednesday, November 6, 2019
PGNX, PRTO, and ARTX SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
Lifshitz & Miller LLP Announces Investigation of Arotech Corporation, Dova Pharmaceuticals, Inc., Highlands Bankshares, Inc., Progenics Pharmaceuticals, Inc., Proteon Therapeutics, Inc., Roan Resources, Inc., SemGroup Corporation and The Stars Group Inc.
AROTECH INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arotech Corporation - ARTX
PRTO, ARTX Shareholder Investigation: Halper Sadeh LLP is Investigating Whether the Sale of These Companies is Fair to Shareholders - PRTO, ARTX

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.